SAN FRANCISCO (MarketWatch) -- Drugmaker Wyeth said late Thursday the Food and Drug Administration approved a delayed-release oral suspension of its heartburn medication Protonix for people who cannot ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results